HOME › DRUGS › INSULIN SUSP ISOPHANE RECOMBINANT HUMAN
ACTIVE SUBSTANCE / INN

INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

Brand name(s): HUMULIN 70/30, HUMULIN N, NOVOLIN 70/30, NOVOLIN N, HUMULIN 70/30 PEN
FDA LISTED
OVER-THE-COUNTER
BLA019959
BLA018781
ACTIVE SUBSTANCE
Insulin Susp Isophane Recombinant Human
REGULATORS
FDA
SPONSORS / MAH
LILLY, NOVO NORDISK INC
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NOVOLIN NBLA019959NOVO NORDISK INCOver-the-counter
HUMULIN NBLA018781LILLYOver-the-counter
HUMULIN 70/30 PENBLA019717LILLYOver-the-counter
HUMULIN 70/30BLA019717LILLYOver-the-counter
NOVOLIN 70/30BLA019991NOVO NORDISK INCOver-the-counter

FULL INTELLIGENCE ON INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →